2015 Rheumatology Year in Review
Was 2015 a good year for psoriasis, IL-17, biosimilars, narcotics, the ACR and gout? Our year end review discusses the most impactful news and research from the last 12 months.
Was 2015 a good year for psoriasis, IL-17, biosimilars, narcotics, the ACR and gout? Our year end review discusses the most impactful news and research from the last 12 months.
I find it interesting that when the Q&A part of the lecture begins, everyone acts as if they just got on the elevator. Who is willing to go out on a limb and ask the first question? Is Q&A the best or worst part of lectures that you attend? What can you do change the impact of your next Q&A experience?
Travel can be challenging for arthritis patients. Here are some useful tips to travel smoothly and pain free.
Notalgia, Lyme disease in Texas and still wearing your hospital ID bracelet? You may have been misdiagnosed and instead have fibromyalgia!
Getting the right drug to the right patient isn’t quite as easy as it should be. Here's a collection of appeal trench war musings and tactics with a sample letter for all to use.
Have crony capitalism and medical administrators overtaken science, logic and common sense in healthcare? Dr. John Goldman reviews some recent developments with some misgivings.
Are you efficient, productive and accurate in what you do? Could you be better? Or do the job differently?
I have a 21 yr. old lupus nephritis patient on mycophenolate, hydroxychloroquine and prednisone 40 mg per day. She says both her current nephrologist and her prior pediatric rheumatologist told her NOT to get pneumococcal and flu vaccines. I thought she is supposed to get them - any comment?
Hospital consults – “nobody goes there anymore”, and not because it’s too crowded (a quote from the late great Yogi Berra), but rather because it’s a poor investment of time and resources.
The American College of Physicians issued a position statement about medical clinics popping up inside of retail establishments and pharmacies. For years now I’ve schemed of starting a national chain of “Jiffy Joints”. Is it time?
Discussions on drug safety can be as treacherous as quicksand for the patient and physician. What the physician knows and what the patient perceives may not be in sync.
Today marks the one year anniversary of hydrocodone becoming a schedule II drug with more restrictive access. Has life been better under these new rules?
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.